Supermicro 8-K
PositiveEarningsNew guidance
Board’s export-control review could change preliminary FY2026 results, prior periods and forecasts.
Filed 2026-08-11 16:06 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q4 and FY2026 results with Q1 and FY2027 revenue guidance. Preliminary results showed higher sales and net income, with Q4 gross margin recovering from the prior-year quarter while full-year gross margin declined. The figures remain subject to closing and review; the company says the Board’s export-control review could affect these results, prior periods and forecasts.
Key Figures
| Metric | Q4 2026 | Q4 2025 | Y/Y |
|---|---|---|---|
| Revenue | $11.1B | $5.76B | +93.2% |
| Operating income | $1.49B | $228M | +551.7% |
| Net income | $1.18B | $195M | +503.9% |
| Diluted EPS | $1.62 | $0.31 | +422.6% |
| Gross margin | 17.5% | 9.5% | +800 bp |
| Non-GAAP gross margin | 17.6% | 9.6% | +800 bp |
| Non-GAAP diluted EPS | $1.70 | $0.41 | +314.6% |
| Metric | FY2026 | FY2025 | Y/Y |
|---|---|---|---|
| Revenue | $39.1B | $22.0B | +77.8% |
| Operating income | $2.77B | $1.25B | +121.1% |
| Net income | $2.23B | $1.05B | +112.7% |
| Diluted EPS | $3.26 | $1.68 | +94.0% |
| Gross margin | 10.8% | 11.1% | −30 bp |
| Non-GAAP gross margin | 10.9% | 11.2% | −30 bp |
| Non-GAAP diluted EPS | $3.63 | $2.06 | +76.2% |
- Operating cash flow was $747M in Q4. FY2026 operating cash flow was $(6.81)B vs $1.66B in FY2025, mainly reflecting increased accounts receivable and inventory; FY2026 capital expenditures were $162M.
- At 6/30/2026, cash and cash equivalents were $7.52B and total bank debt and convertible notes were $8.7B. The company reported more than $60B in new orders over the past year and record backlog entering FY2027.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Revenue | Q1 FY2027 | $14.5B-$15.5B | — | — |
| GAAP diluted EPS | Q1 FY2027 | $0.89-$0.98 | — | — |
| Non-GAAP diluted EPS | Q1 FY2027 | $1.01-$1.10 | — | — |
| Revenue | FY2027 | $65.0B-$72.0B | — | — |
Q1 EPS assumptions include tax rates of approximately 20.1% GAAP and 20.5% non-GAAP, and diluted share counts of 745M GAAP and 761M non-GAAP. GAAP EPS includes approximately $106M of stock-based compensation expense, net of $32M in related tax effects, excluded from non-GAAP EPS.
Investor Takeaways
- Final FY2026 results may differ from these preliminary figures as the company completes its close and review; the Board’s export-control review is another stated source of potential changes.
- Q1 FY2027 results and the FY2027 revenue range will show whether sales momentum and profitability continue.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3